AAQ1 Fundamental Analysis - AAP IMPLANTATE

Fundamental Rating

Taking everything into account, AAQ1 scores 2 out of 10 in our fundamental rating. AAQ1 was compared to 68 industry peers in the Health Care Equipment & Supplies industry. The financial health of AAQ1 is average, but there are quite some concerns on its profitability. While showing a medium growth rate, AAQ1 is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AAQ1 has reported negative net income.

In the past year AAQ1 has reported a negative cash flow from operations.

AAQ1 had negative earnings in each of the past 5 years.

AAQ1 had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

AAQ1's Return On Assets of -25.96% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 77.94% of its industry peers.

AAQ1's Return On Equity of -38.70% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 75.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-25.96%
ROE	-38.7%
ROIC	N/A

ROA(3y)-27.22%

ROA(5y)-27.6%

ROE(3y)-50.99%

ROE(5y)-51.91%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AAQ1 has a better Gross Margin (87.45%) than 97.06% of its industry peers.

In the last couple of years the Gross Margin of AAQ1 has remained more or less at the same level.

AAQ1 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	87.45%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.81%

GM growth 5Y-0.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.

AAQ1 has more shares outstanding than it did 1 year ago.

AAQ1 has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, AAQ1 has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.10, we must say that AAQ1 is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.10, AAQ1 is doing worse than 72.06% of the companies in the same industry.

AAQ1 has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of AAQ1 (0.03) is better than 88.24% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	-0.1

ROIC/WACCN/A

WACC6.89%

2.3 Liquidity

AAQ1 has a Current Ratio of 2.40. This indicates that AAQ1 is financially healthy and has no problem in meeting its short term obligations.

AAQ1 has a better Current ratio (2.40) than 70.59% of its industry peers.

A Quick Ratio of 1.24 indicates that AAQ1 should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.24, AAQ1 is in line with its industry, outperforming 54.41% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.4
Quick Ratio	1.24

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.21% over the past year.

The Revenue has been growing slightly by 6.32% in the past year.

The Revenue has been growing slightly by 0.78% on average over the past years.

EPS 1Y (TTM)63.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.53%

Revenue 1Y (TTM)6.32%

Revenue growth 3Y0.1%

Revenue growth 5Y0.78%

Sales Q2Q%-3.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

AAQ1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.66% yearly.

EPS Next Y65%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year15.38%

Revenue Next 2Y22.14%

Revenue Next 3Y12.95%

Revenue Next 5Y11.66%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AAQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AAQ1. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AAQ1!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

AAP IMPLANTATE

FRA:AAQ1 (1/8/2026, 7:00:00 PM)

1.44

+0.07 (+5.11%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)09-16 2025-09-16

Earnings (Next)06-18 2026-06-18

Inst Owners22.99%

Inst Owner ChangeN/A

Ins Owners10.14%

Ins Owner ChangeN/A

Market Cap20.03M

Revenue(TTM)12.20M

Net Income(TTM)-3.63M

Analysts42.22

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.64
P/FCF	N/A
P/OCF	N/A
P/B	2.14
P/tB	2.66
EV/EBITDA	N/A

EPS(TTM)-0.35

EYN/A

EPS(NY)-0.07

Fwd EYN/A

FCF(TTM)-0.06

FCFYN/A

OCF(TTM)-0.02

OCFYN/A

SpS0.88

BVpS0.67

TBVpS0.54

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-25.96%
ROE	-38.7%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	87.45%
FCFM	N/A

ROA(3y)-27.22%

ROA(5y)-27.6%

ROE(3y)-50.99%

ROE(5y)-51.91%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.81%

GM growth 5Y-0.65%

F-Score6

Asset Turnover0.87

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	32.08%
Cap/Sales	4.82%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.4
Quick Ratio	1.24
Altman-Z	-0.1

F-Score6

WACC6.89%

ROIC/WACCN/A

Cap/Depr(3y)18.89%

Cap/Depr(5y)19.66%

Cap/Sales(3y)3.48%

Cap/Sales(5y)3.84%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)63.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.53%

EPS Next Y65%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)6.32%

Revenue growth 3Y0.1%

Revenue growth 5Y0.78%

Sales Q2Q%-3.32%

Revenue Next Year15.38%

Revenue Next 2Y22.14%

Revenue Next 3Y12.95%

Revenue Next 5Y11.66%

EBIT growth 1Y61.47%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year173.33%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y63.88%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y86.19%

OCF growth 3YN/A

OCF growth 5YN/A

AAP IMPLANTATE / AAQ1.DE FAQ

What is the fundamental rating for AAQ1 stock?

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE.

Can you provide the valuation status for AAP IMPLANTATE?

ChartMill assigns a valuation rating of 0 / 10 to AAP IMPLANTATE (AAQ1.DE). This can be considered as Overvalued.

What is the profitability of AAQ1 stock?

AAP IMPLANTATE (AAQ1.DE) has a profitability rating of 1 / 10.

Can you provide the expected EPS growth for AAQ1 stock?

The Earnings per Share (EPS) of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 65% in the next year.

AAP IMPLANTATE (AAQ1.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AAP IMPLANTATE / AAQ1.DE FAQ

What is the fundamental rating for AAQ1 stock?

Can you provide the valuation status for AAP IMPLANTATE?

What is the profitability of AAQ1 stock?

Can you provide the expected EPS growth for AAQ1 stock?